Quantity size:
0.1ml
Concentration:
1mg/ml 磷酸化星形胶质细胞升高基因1抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
LYRIC is a type II membrane protein, the precise role of which has yet to be defined. It is expressed in breast and prostate carcinoma and is a potential mediator of lung metastasis. It 磷酸化星形胶质细胞升高基因1抗体has also been found in mouse Purkinje neurons and cerebellum. In epithelial cells it is recruited to tight junctions (TJ) during the maturation of the TJ complexes. LYRIC co-localizes with beta-catenin in normal and tumour tissues.
磷酸化星形胶质细胞升高基因1抗体Also known as:
LYRIC (phospho S568); p-LYRIC (phospho S568); 3D3; 3D3/LYRIC; AEG 1; AEG-1; AEG1; Astrocyte elevated gene 1; Astrocyte elevated gene-1 protein; LYRIC; LYRIC/3D3; LYRIC_HUMAN; Lysine rich CEACAM1 associated protein; Lysine rich CEACAM1 co isolated protein; Lysine-rich CEACAM1 co-isolated protein; Metadherin; Metastasis adhesion protein; MTDH; Protein LYRIC.
Specificity:
●
Rabbit Polyclonal IgG,磷酸化星形胶质细胞升高基因1抗体 affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human LYRIC around the phosphorylation site of Ser568.
●
Predicted Molecular Weight: 64kDa.
磷酸化星形胶质细胞升高基因1抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl421Hu01髓鞘少突胶质细胞糖蛋白(MOG)多克隆抗体Polyclonal Antibody to Myelin Oligodendrocyte Glycoprotein (MOG)
kl421Mu01髓鞘少突胶质细胞糖蛋白(MOG)多克隆抗体Polyclonal Antibody to Myelin Oligodendrocyte Glycoprotein (MOG)
kl421Ra01髓鞘少突胶质细胞糖蛋白(MOG)多克隆抗体Polyclonal Antibody to Myelin Oligodendrocyte Glycoprotein (MOG)
kl049Hu01干扰素γ(IFNγ)多克隆抗体Polyclonal Antibody to Interferon Gamma (IFNg)
kl049Mu01干扰素γ(IFNγ)多克隆抗体Polyclonal Antibody to Interferon Gamma (IFNg)
kl049Ra01干扰素γ(IFNγ)多克隆抗体Polyclonal Antibody to Interferon Gamma (IFNg)
kl146Hu01血管内皮生长因子D(VEGFD)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Mu01血管内皮生长因子D(VEGFD)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Ra01血管内皮生长因子D(VEGFD)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl145Hu01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Mu01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Ra01血管内皮生长因子C(VEGFC)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl144Hu01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Mu01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Ra01血管内皮生长因子B(VEGFB)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl143Hu01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Mu01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ra01血管内皮生长因子A(VEGFA)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl949Hu01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Mu01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Ra01转化生长因子β3(TGFβ3)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl218Hu01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Mu01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Ra01转化生长因子β2(TGFβ2)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话